Jeffrey Fink - Jun 8, 2022 Form 4 Insider Report for Lipocine Inc. (LPCN)

Role
Director
Signature
/s/ Jeffrey Fink
Stock symbol
LPCN
Transactions as of
Jun 8, 2022
Transactions value $
$20,240
Form type
4
Date filed
6/10/2022, 11:33 AM
Previous filing
Jun 10, 2021
Next filing
May 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Common Stock (Right to Buy) Award $20.2K +22K +19.3% $0.92 136K Jun 8, 2022 Common Stock 22K $0.92 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

1. 100% vesting one year from date of grant.